Oncology PracticeBrentuximab doubles PFS in Hodgkin’s lymphoma patientsMarch 18, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasHodgkin Lymphoma
Hematology NewsAutologous stem-cell transplant boosts survival in sequential transformed indolent lymphomaDecember 11, 2014Aggressive LymphomasFollicular Lymphoma
Hematology NewsBrentuximab changes landscape for post-transplant Hodgkin’s lymphoma patientsDecember 7, 2014Rare DiseasesTransfusion MedicineAggressive LymphomasCellular TherapyHodgkin Lymphoma
Hematology NewsPD-1 checkpoint inhibitors show mettle against relapsed Hodgkin’s lymphomaDecember 7, 2014Transfusion MedicineAggressive LymphomasHodgkin Lymphoma
Hematology NewsRepeat biopsy and long-term surveillance key for rare Hodgkin’s lymphoma subtype June 20, 2014Aggressive LymphomasHodgkin Lymphoma
Oncology PracticeVIDEO: Idelalisib shows promise in refractory non-Hodgkin lymphomaDecember 10, 2013Lymphoma & Plasma Cell DisordersAggressive LymphomasHodgkin Lymphoma
